Kasia Kozlowski

1.6k total citations · 1 hit paper
16 papers, 1.2k citations indexed

About

Kasia Kozlowski is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Kasia Kozlowski has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Genetics. Recurrent topics in Kasia Kozlowski's work include Medical Imaging Techniques and Applications (6 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Kasia Kozlowski is often cited by papers focused on Medical Imaging Techniques and Applications (6 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Kasia Kozlowski collaborates with scholars based in United Kingdom, France and Italy. Kasia Kozlowski's co-authors include Dragana Milojković, John M. Goldman, David Marín, Letizia Foroni, Marco Bua, Alistair Reid, Jane F. Apperley, Lina Eliasson, Christos Paliompeis and Richard Szydlo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Molecules.

In The Last Decade

Kasia Kozlowski

16 papers receiving 1.2k citations

Hit Papers

Adherence Is the Critical Factor for Achieving Molecular ... 2010 2026 2015 2020 2010 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib
    2010 674 citations David Marín, Alexandra Bazeos et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kasia Kozlowski United Kingdom 11 712 670 306 202 181 16 1.2k
François-Xavier Mahon France 10 830 1.2× 721 1.1× 368 1.2× 139 0.7× 126 0.7× 11 1.0k
Christos Paliompeis United Kingdom 8 1.2k 1.8× 1.1k 1.7× 620 2.0× 141 0.7× 181 1.0× 11 1.5k
Weiwei Feng China 18 220 0.3× 208 0.3× 85 0.3× 240 1.2× 124 0.7× 38 1.3k
Marco Bua United Kingdom 18 2.3k 3.2× 2.0k 3.0× 1.3k 4.1× 246 1.2× 184 1.0× 32 2.6k
Carmen Fava Italy 18 562 0.8× 412 0.6× 200 0.7× 167 0.8× 2 0.0× 91 973
Arleigh McCurdy Canada 14 1.4k 2.0× 249 0.4× 46 0.2× 918 4.5× 7 0.0× 92 1.8k
Clarisse Lobo Brazil 12 1.3k 1.8× 1.1k 1.7× 647 2.1× 195 1.0× 2 0.0× 24 1.5k
Yan Song United States 20 126 0.2× 62 0.1× 167 0.5× 613 3.0× 8 0.0× 132 1.5k
Farhad Ravandi‐Kashani United States 20 674 0.9× 585 0.9× 161 0.5× 246 1.2× 1 0.0× 96 1.4k
Jacques Camerlo France 18 212 0.3× 105 0.2× 16 0.1× 448 2.2× 6 0.0× 50 932

Countries citing papers authored by Kasia Kozlowski

Since Specialization
Citations

This map shows the geographic impact of Kasia Kozlowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kasia Kozlowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kasia Kozlowski more than expected).

Fields of papers citing papers by Kasia Kozlowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kasia Kozlowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kasia Kozlowski. The network helps show where Kasia Kozlowski may publish in the future.

Co-authorship network of co-authors of Kasia Kozlowski

This figure shows the co-authorship network connecting the top 25 collaborators of Kasia Kozlowski. A scholar is included among the top collaborators of Kasia Kozlowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kasia Kozlowski. Kasia Kozlowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Challapalli, Amarnath, Tara Barwick, Suraiya Dubash, et al.. (2023). Bench to Bedside Development of [18F]Fluoromethyl-(1,2-2H4)choline ([18F]D4-FCH). Molecules. 28(24). 8018–8018. 1 indexed citations
2.
3.
Dubash, Suraiya, Nicholas Keat, Kasia Kozlowski, et al.. (2020). Clinical translation of 18F-fluoropivalate – a PET tracer for imaging short-chain fatty acid metabolism: safety, biodistribution, and dosimetry in fed and fasted healthy volunteers. European Journal of Nuclear Medicine and Molecular Imaging. 47(11). 2549–2561. 10 indexed citations
4.
5.
Dubash, Suraiya, Kathrin Heinzmann, Francesco Mauri, et al.. (2018). Clinical translation of [18F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 45(13). 2285–2299. 31 indexed citations
6.
Dubash, Suraiya, Tara Barwick, Francesco Mauri, et al.. (2018). [18F]FET-βAG-TOCA versus [68Ga]DOTATATE PET/CT in functional imaging of neuroendocrine tumours.. Journal of Clinical Oncology. 36(15_suppl). e24193–e24193. 2 indexed citations
7.
Dubash, Suraiya, Nicholas Keat, Paola Mapelli, et al.. (2016). Clinical Translation of a Click-Labeled 18F-Octreotate Radioligand for Imaging Neuroendocrine Tumors. Journal of Nuclear Medicine. 57(8). 1207–1213. 33 indexed citations
8.
Saleem, Azeem, Graham E. Searle, Laura Kenny, et al.. (2015). Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer. EJNMMI Research. 5(1). 30–30. 58 indexed citations
9.
Challapalli, Amarnath, Sebastian Trousil, Steve Hazell, et al.. (2015). Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer. Journal of Clinical Pathology. 68(9). 703–709. 20 indexed citations
10.
Challapalli, Amarnath, Rohini Sharma, William Hallett, et al.. (2014). Biodistribution and Radiation Dosimetry of Deuterium-Substituted 18F-Fluoromethyl-[1, 2-2H4]Choline in Healthy Volunteers. Journal of Nuclear Medicine. 55(2). 256–263. 21 indexed citations
11.
Challapalli, Amarnath, Laura Kenny, William Hallett, et al.. (2013). 18F-ICMT-11, a Caspase-3–Specific PET Tracer for Apoptosis: Biodistribution and Radiation Dosimetry. Journal of Nuclear Medicine. 54(9). 1551–1556. 74 indexed citations
12.
Saleem, Azeem, Graham E. Searle, Laura Kenny, et al.. (2013). Brain and tumor penetration of carbon-11–labeled lapatinib ([11C]Lap) in patients (pts) with HER2-overexpressing metastatic breast cancer (MBC).. Journal of Clinical Oncology. 31(15_suppl). 635–635. 2 indexed citations
13.
Ibrahim, Amr R., Lina Eliasson, Jane F. Apperley, et al.. (2011). Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy. Blood. 117(14). 3733–3736. 246 indexed citations
14.
Marín, David, Alexandra Bazeos, François-Xavier Mahon, et al.. (2010). Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib. Journal of Clinical Oncology. 28(14). 2381–2388. 674 indexed citations breakdown →
15.
Bazeos, A., Jamshid S. Khorashad, François‐Xavier Mahon, et al.. (2009). Long Term Adherence to Imatinib Therapy Is the Critical Factor for Achieving Molecular Responses in Chronic Myeloid Leukemia Patients.. Blood. 114(22). 3290–3290. 15 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by François-Xavier Mahon Breakdown of academic impact, for papers by Christos Paliompeis Breakdown of academic impact, for papers by Weiwei Feng Breakdown of academic impact, for papers by Marco Bua Breakdown of academic impact, for papers by Carmen Fava Breakdown of academic impact, for papers by Arleigh McCurdy Breakdown of academic impact, for papers by Clarisse Lobo Breakdown of academic impact, for papers by Yan Song Breakdown of academic impact, for papers by Farhad Ravandi‐Kashani Breakdown of academic impact, for papers by Jacques Camerlo
Rankless by CCL
2026